BIOPHARMATEK
ActiveBIOPHARMATEK has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €228k and a net result of €52k. Equity is growing by ~61.6% per year across the filed fiscal years. Its solvency ranks better than 62% of 15868 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 1.3% (low).
Checked score
Score 2024
75
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability85▼-6
Solvency80▼-11
Growth78=
Track record100
Bankruptcy probability, 12 months
1.3%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €17k at 30 days acceptable
Liquidity ample (current ratio 2.21 against 2.94 in 2023; short-term debt: 44.9% and cash: 40.8% of total assets), and 44.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-07-2025, 2 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
not confirmed
2024
2 d early
2023
2 d early
2022
7 d early
2021
31 d late
2020
90 d late
2019
90 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€52k▼ 24.9%
2023 · €70k
2018: €5k
2019: €21k
2020: €5k
2021: €37k
2022: €101k
2023: €70k
2018 → 2024
Working capital
€226k▼ 11.4%
2023 · €255k
2018: €15k
2019: €36k
2020: €41k
2021: €76k
2022: €184k
2023: €255k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€43k-€80k▲ 87.5%€187k▲ 134%€257k▲ 37.2%€228k▼ 11.1%
Operating result€8k-€54k▲ 588%€144k▲ 168%€96k▼ 33.5%€70k▼ 26.6%
Net result€5k-€37k▲ 644%€101k▲ 170%€70k▼ 30.9%€52k▼ 24.9%
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2024 is 27% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €415k
Fixed assets
€3k▲ 30.9%
Current assets
€412k▲ 6.7%
Equity and liabilities €415k
Equity
€228k▼ 11.1%
Debt
€186k▲ 42.0%
The debt ratio rises from 33.8% to 44.9%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€71k▼
2023 · €97k
Cash flow
€53k▼
2023 · €71k
Solvency
55.1%▼
2023 · 66.2%
Current ratio
2.21▼
2023 · 2.94
Quick ratio
2.12▲
2023 · 1.61
Debt / equity
0.82▲
2023 · 0.51
ROE
22.9%▼
2023 · 27.1%
ROA
12.6%▼
2023 · 18.0%
Interest coverage
211.10▼
2023 · 744.56
Debt
€186k▲
2023 · €131k
Debt ≤ 1 year
€186k▲
2023 · €131k
Income taxes
€18k▼
2023 · €26k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€388k€415k▲
Fixed assets21/28€2k€3k▲
Tangible fixed assets22/27€1k€2k▲
Plant, machinery and equipment23€747€554▼
Furniture and vehicles24€324€1k▲
Financial fixed assets28€931€931=
Current assets29/58€386k€412k▲
Stocks and contracts in progress3€175k€17k▼
Stocks30/36€175k€17k▼
Amounts receivable within one year40/41€107k€226k▲
Trade receivables40€70k€158k▲
Other amounts receivable41€37k€67k▲
Cash at bank and in hand54/58€104k€169k▲
Equity and liabilities
Total equity and liabilities10/49€388k€415k▲
Equity10/15€257k€228k▼
Contributions10/11€20k€20k=
Reserves13€213k€208k▼
Distributable reserves133€213k€208k▼
Profit (loss) carried forward14€23k-
Amounts payable17/49€131k€186k▲
Amounts payable within one year42/48€131k€186k▲
Trade debts44€6k€4k▼
Suppliers440/4€6k€4k▼
Advances received on contracts in progress46€99k€59k▼
Taxes, remuneration and social security45€26k€56k▲
Taxes450/3€26k€56k▲
Other amounts payable47/48-€67k
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€890€494▼
Other operating charges640/8€31k€997▼
Gross operating margin9900€128k€72k▼
Operating profit (loss)9901€96k€70k▼
Financial income75/76B€10€87▲
Recurring financial income75€10€87▲
Financial charges65/66B€130€336▲
Recurring financial charges65€130€336▲
Profit (loss) for the period before taxes9903€96k€70k▼
Income taxes67/77€26k€18k▼
Profit (loss) for the period9904€70k€52k▼
Profit (loss) for the period to be appropriated9905€70k€52k▼
Appropriation of the result
Profit (loss) to be appropriated9906€93k€76k▼
Profit (loss) brought forward from the previous period14P€23k€23k=
Transfer from equity791/2-€5k
Transfer to equity691/2€70k-
To other reserves6921€70k-
Profit to be distributed694/7-€81k
Return on contributions (dividend)694-€81k
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
29-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
29-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Liquidity doublescurrent ratio 2.94
Current ratio from 1.24 to 2.94; short-term debt falls from €774k to €131k.
31-12
Financial
Equity above €200kEq €257k ▲37.2%
6 profitable years in a row build equity to €257k.
24-07
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial
Highest result since 2018net €101k ▲170%
Operating result €144k, net result €101k, both a record.
31-12
Financial
Equity above €150kEq €187k ▲134%
5 profitable years in a row build equity to €187k.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 31 days late
2021
29-10
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 90 days late
2020
29-10
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 90 days late
2019
28-10
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 89 days late
2018
27-09
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 58 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Lambrechts-Woluwe · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Veldkapelgaarde 301200 Sint-Lambrechts-WoluweGround area
2,855 m²
Building footprint
1,311 m²
Volume, LiDAR
34,985 m³
2 parcels, Brussels · tallest building 32.8 m, ±10 floors. Linked by address, not a title deed.
1 establishment unit
Biopharmatek
since 20172.264.513.795
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21018B0260/00A000 | Brussels | 2,681 m² | 1 · 1,193 m² | 32.8 m · 10 fl. |
| 21017D0163/00S003 | Brussels | 173 m² | 1 · 118 m² | 13.6 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
W4JU
BE 0777.908.722
Namur · Eq €228k
DELACO
BE 0809.327.418
Roeselare · Eq €228k
MM Interieur
BE 0891.470.877
Herentals · Eq €229k
SVR Advies
BE 0849.396.831
Gavere · Eq €230k
V.P. Entreprise
BE 0500.557.612
Overijse · Eq €227k
Of 4,426 companies in sector 46180 we hold annual accounts for 1,886. 1,341 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded12-05-2017
Fiscal year end31-12
Activities, NACEBEL
46180Agents specialised in the wholesale of other particular products
46500Wholesale of information and communication equipment
46649Wholesale of other machinery and equipment
46660Wholesale trade
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.